Generic Herceptin (Trastuzumab) — Same Medicine, 85% Less
FDA-approved Trastuzumab biosimilar — the generic equivalent of Herceptin. Same monoclonal antibody, same HER2-targeting efficacy, dramatically lower cost.
Brand vs. Generic Comparison
| Specification | Herceptin (Brand) | Generic Trastuzumab Biosimilar |
|---|---|---|
| Active Ingredient | Trastuzumab (monoclonal antibody) | Trastuzumab (monoclonal antibody) |
| Formulation | 150mg/vial IV infusion | 150mg/vial IV infusion |
| Manufacturer | Roche (Switzerland/Germany) | Natco / Cipla / Biocon (India, WHO-GMP certified) |
| Average Course Cost | $300,000–$500,000 per course (1 year+) | $45,000–$85,000 per course |
| Biosimilar Equivalent | ✓ Reference Standard | ✓ FDA-Approved Biosimilar |
| Indication | HER2-positive breast cancer | HER2-positive breast cancer |
How It Works
Trastuzumab is a monoclonal antibody that targets the HER2 protein on cancer cells. HER2-positive breast cancers produce excess HER2 protein, which promotes tumor growth. Trastuzumab binds to HER2, blocking growth signals and helping the immune system destroy cancer cells.
Biosimilar Equivalence: Trastuzumab biosimilars are biologic drugs designed to be highly similar to the reference product (Herceptin). Biosimilars undergo extensive analytical, animal, and clinical studies to demonstrate safety and efficacy equivalent to the brand-name biologic. FDA-approved biosimilars are considered interchangeable with the brand drug.
Trust Block: Biosimilar Safety & Efficacy
Biosimilars are not “generic” in the traditional sense—they are complex biologic drugs manufactured from living cells. However, they are therapeutically equivalent to their brand counterparts, as proven by rigorous FDA and EMA approval processes. Thousands of patients worldwide receive biosimilar Trastuzumab with identical outcomes to Herceptin.
OnlineMeds Assurance: All Trastuzumab products are sourced from WHO-GMP certified biopharmaceutical facilities. Each infusion is reviewed by a licensed medical professional, and we provide complete documentation of storage conditions (required 2–8°C) to ensure efficacy.
Administration
This information is educational only. Always follow your physician’s instructions.
- Formulation: 150mg/vial, reconstituted and diluted for IV infusion
- Loading Dose: Typically 8 mg/kg IV infusion over 90 minutes
- Maintenance Dose: 6 mg/kg IV infusion every 3 weeks over 30–60 minutes
- Total Duration: Usually 1 year of treatment (approximately 18 infusions)
- Administration Site: Must be administered by a licensed healthcare provider (hospital or infusion center)
Why Choose Generic Trastuzumab Biosimilar?
- Massive Cost Savings: 85%+ less than Herceptin (~$300,000 vs. ~$45,000–$85,000 per course)
- Same Monoclonal Antibody: FDA-approved biosimilar with identical HER2-targeting mechanism
- Proven Safety & Efficacy: Thousands of patients treated with identical outcomes
- WHO-GMP Certified Manufacturing: Biopharmaceutical-grade quality control
- Licensed Professional Review: Every order verified by a medical professional
How to Order
5-Step Process:
- Upload Your Prescription: Provide a valid prescription from your oncologist (photo or PDF)
- Confirm Infusion Arrangement: Trastuzumab must be administered by a licensed infusion center. We can advise on international infusion providers.
- Secure Payment: Use Visa, Mastercard, or other secure payment methods
- Pharmacist Review: Our licensed pharmacist verifies your prescription (24–48 hours)
- Shipment with Cold Chain: Your order ships via international courier with temperature-controlled packaging (7–14 business days). Trastuzumab requires 2–8°C storage.
Browse Trastuzumab & Breast Cancer Medications
Frequently Asked Questions
- Is Trastuzumab biosimilar as effective as Herceptin?
- Yes. FDA-approved Trastuzumab biosimilars are proven to be therapeutically equivalent to Herceptin. Clinical studies show identical efficacy in treating HER2-positive breast cancer. Your oncologist would not distinguish between them in terms of outcome.
- Is Trastuzumab administered the same way as Herceptin?
- Yes. Trastuzumab biosimilars are administered identically: IV infusion every 3 weeks, loading dose followed by maintenance doses. The infusion protocol, timing, and monitoring are identical to Herceptin. Both require administration at a licensed infusion center.
- Is a prescription required?
- Yes. Trastuzumab is a prescription-only biologic medication for HER2-positive breast cancer. You must provide a valid prescription from an oncologist. We verify every prescription with a licensed medical professional.
- Where can I receive Trastuzumab infusions?
- Trastuzumab is administered intravenously and must be given by a licensed healthcare provider (hospital, cancer center, or specialized infusion clinic). OnlineMeds can help you locate licensed international infusion centers if you are outside the U.S.
- How much can I save with generic Trastuzumab?
- Brand-name Herceptin costs approximately $300,000–$500,000 per full course (1 year of treatment) in the U.S. Generic/biosimilar Trastuzumab from OnlineMeds costs $45,000–$85,000 per course. That’s an 85%+ savings. For a full 1-year course, you could save $215,000–$455,000.
- Is Trastuzumab safe?
- Like all cancer medications, Trastuzumab carries potential side effects including heart problems, lung toxicity, and allergic reactions. Your oncologist will monitor you closely with echocardiograms and regular blood tests. Discuss any concerns with your physician before starting treatment.
Storage & Handling
Trastuzumab is a biologic and requires special handling:
- Storage Temperature: 2–8°C (refrigerated)
- Do Not Freeze: Freezing damages the protein structure
- Shelf Life: 3 years when properly stored
- OnlineMeds ships all Trastuzumab with insulated, temperature-controlled packaging to maintain the cold chain
Legal Disclaimer
This content is for informational purposes only and should not be construed as medical advice, a diagnosis, or a recommendation for treatment. Trastuzumab is a potent biologic cancer medication that requires ongoing medical supervision and administration by licensed healthcare professionals. Always use it only as prescribed by your oncologist. OnlineMeds is not a substitute for medical care. If you have questions about whether biosimilar Trastuzumab is right for you, contact your healthcare provider.
Biosimilars are legally and therapeutically equivalent to their reference biologics when FDA-approved. OnlineMeds operates in compliance with international pharmaceutical regulations and does not replace the role of your oncologist.